SCHEMBL28059306

SCHEMBL28059306

CC(C)(C)C(=O)ON1CCC(c2ccccc2COS(C)(=O)=O)CC1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCRTR2 O43614 1/20 0.36
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
RBP4 P02753 2/20 0.34
NAAA Q02083 1/20 0.34
HTR6 P50406 3/20 0.33
DRD3 P35462 2/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
SSTR1 P30872 1/20 0.33
SSTR4 P31391 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 2/20 0.32
GPR119 Q8TDV5 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28789641 0.86 ALDH1A1 (0.38) MEN1KMT2AHTR6CYP1A2CYP3A4
SCHEMBL2334032 0.83 STS (0.48) MAPTGPR119SMN1; SMN2
SCHEMBL2364532 0.81 MEN1 (0.43) HCRTR2MEN1KMT2ARBP4SLC6A2
SCHEMBL27821349 0.74 SLC6A2 (0.37) MEN1KMT2ARBP4HTR6SLC6A2
SCHEMBL28298593 0.74 MEN1 (0.59) MEN1KMT2AMAPT
SCHEMBL22524566 0.73 STS (0.49) MAPTGPR119SMN1; SMN2
SCHEMBL27811329 0.72 RBP4 (0.48) HCRTR2MEN1KMT2ARBP4SMN1; SMN2
SCHEMBL14639250 0.72 ELANE (0.50) MAPT
SCHEMBL27488566 0.72 RIPK1 (0.51)
SCHEMBL15434568 0.72 KDM4E (0.41) MEN1KMT2ACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109640989-A Compounds for the treatment of neurogenic orthostatic hypotension 施万生物制药研发IP有限责任公司 2019-04-16 CN disclosed
CN-102209712-B Process for preparing 4- [2- (2-fluorophenoxymethyl) phenyl ] piperidine compounds THERAVANCE BIOPHARMA R&D IP, LLC (US) 2016-04-06 CN disclosed